Approval · Notice of Compliance 11788 · 2010
PROTOPIC: Notice of Compliance 11788
Issued October 6, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11788
- Date
- October 6, 2010
- Company
- Astellas Pharma Canada IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a maintenance indication
- Therapeutic class
- Topical calcineurin inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROTOPIC | Not yet assigned | — |
Medicinal ingredients
- TACROLIMUS 0.03 PER
- TACROLIMUS 0.1 PER